Novotech (Australia) Pty Ltd:製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Novotech (Australia) Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C7546)・商品コード:DATA904C7546
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:26
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥55,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥82,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Novotech (Australia) Pty Ltd (Novotech) is a contract research organization that offers clinical development services. The organization’s services include clinical trials, data management, biostatistics analysis, audits, regulatory affairs, medical writing, site management and commercialization services. It provides clinical trial services in the therapeutic areas of analgesia, dermatology, cardiovascular, oncology, endocrinology, anti-infectives, gastroenterology, ophthalmology, psychiatry, respiratory and allergy, rheumatology, infectious diseases and hematology, among others. Novotech caters its clinical outsourcing services to biotechnology and pharmaceutical companies. The organization has operations in Australia, Hong Kong, New Zealand, China, India, South Korea, Taiwan, Thailand, Malaysia, the Philippines and Singapore. Novotech is headquartered in Sydney, New South Wales, Australia.

Novotech (Australia) Pty Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Novotech (Australia) Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Novotech (Australia) Pty Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Novotech (Australia) Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Novotech (Australia) Pty Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Novotech (Australia) Pty Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Novotech (Australia) Pty Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
TPG Capital May Acquire Majority Stake in Novotech from Mercury Capital 10
Mercury Capital Acquires 30% Stake In Novotech, Contract Research Organization 11
Partnerships 12
Imugene Enters into Agreement with Novotech 12
Novogen Enters into Contract Research Agreement with Novotech 13
Novotech (Australia) Pty Ltd – Key Competitors 14
Novotech (Australia) Pty Ltd – Key Employees 15
Novotech (Australia) Pty Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 18
Government and Public Interest 18
May 17, 2018: Novotech says Federal Budget R&D Tax Support Keeps Australia Globally Competitive for Quality Clinical Trials 18
Jan 09, 2018: Australia and Asia Pacific offer international biotech industry a wealth of clinical trial and costs benefits 19
Nov 30, 2017: Malaysian government invests in its early stage research industry and launches new Phase I clinical trial guidelines 20
Oct 23, 2017: China implements 5 key changes to accelerate clinical trial and drug approval timelines 21
Oct 05, 2017: Taiwan simplifies its First In Human regulatory process, reducing timelines by up to 3 months 23
Oct 03, 2017: EMA releases addendum to ICH Guidelines, highlighting importance of considering treatment effects when planning clinical trials 24
Other Significant Developments 25
Nov 30, 2017: Novotech Update: Malaysian government invests in its early stage research industry and launches new Phase I clinical trial guidelines 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Novotech (Australia) Pty Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Novotech (Australia) Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Novotech (Australia) Pty Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Novotech (Australia) Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Novotech (Australia) Pty Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Novotech (Australia) Pty Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TPG Capital May Acquire Majority Stake in Novotech from Mercury Capital 10
Mercury Capital Acquires 30% Stake In Novotech, Contract Research Organization 11
Imugene Enters into Agreement with Novotech 12
Novogen Enters into Contract Research Agreement with Novotech 13
Novotech (Australia) Pty Ltd, Key Competitors 14
Novotech (Australia) Pty Ltd, Key Employees 15
Novotech (Australia) Pty Ltd, Other Locations 16
Novotech (Australia) Pty Ltd, Subsidiaries 17

List of Figures
Novotech (Australia) Pty Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Novotech (Australia) Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Novotech (Australia) Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Novotech (Australia) Pty Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Novotech (Australia) Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Novotech (Australia) Pty Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Novotech (Australia) Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Novotech (Australia) Pty Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★調査レポート[Novotech (Australia) Pty Ltd:製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C7546)販売に関する免責事項を必ずご確認ください。
★調査レポート[Novotech (Australia) Pty Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆